Inter-tumor heterogeneity

Mike Cusnir, Ludmila Cavalcante

Research output: Contribution to journalComment/debatepeer-review

19 Scopus citations


Advances in the molecular study of cancer have focused on biomarkers in the setting of tumor-driving mutations within the great heterogeneity of the tumor genomic landscape. It is clearly recognized now that even two tumors originating from the same organ even if histological they appear similar their behavior and response to therapy can be different. These findings have increased interest and research to find truly prognostic and predictive biomarkers to serve as tools in better assessing the natural course of disease and response to treatments in the hope of truly individualizing cancer therapy in the future.

Original languageEnglish (US)
Pages (from-to)1143-1145
Number of pages3
JournalHuman Vaccines and Immunotherapeutics
Issue number8
StatePublished - Aug 2012
Externally publishedYes

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Pharmacology


Dive into the research topics of 'Inter-tumor heterogeneity'. Together they form a unique fingerprint.

Cite this